Ecolab Inc.

(New York Stock Exchange)

Top News rankings and signal summaries are processed using AI and may contain errors.

21
Bullish +75

Ecolab Q1 Earnings Call Highlights

Ecolab (NYSE:ECL) reported strong Q1 results with adjusted diluted earnings per share increasing 13% and organic sales growing 4%, driven by value pricing of 3% and volume growth of 1%. The company expanded its organic operating income margin by 70 basis points to reach 16.8%,...

Bullish Signals

  • Ecolab delivered strong Q1 results with adjusted diluted EPS up 13%.
  • Organic operating income margin expanded 70 basis points to 16.8%.
  • CEO Christophe Beck praised accelerating momentum and met EPS guidance.
  • Global High-Tech and digital businesses grew over 20% driven by AI.
  • Life Sciences segment accelerated to 11% growth led by bioprocessing.
  • Pest Elimination deploys 700,000 smart devices targeting 1 million by year-end.
  • Core portfolio businesses including Specialty (+9%) and Food & Beverage (+5%) grew well.
  • Energy surcharge effective April 1 protects margins from rising costs.

Bearish Signals

  • $0.20 EPS dilution in Q3; neutrality not until 2027.
  • Q2 growth trimmed by higher commodity costs and energy transition.
  • Life Sciences margins target 30% but hover in mid-20s now.
  • New plant opening pressures short-term profitability through year-end.
  • Q1 gross margin 'slightly low' from M&A impacts and inflation.
  • Middle East conflict strains global supply chains and production.
22
Somewhat Bullish +50

EcoLab Posts Higher 1Q Sales, Adds Energy Surcharge to Offset Fuel Costs

EcoLab Inc., a global water and hygiene products company, reported strong financial performance for the first quarter ended March 31, 2026, with revenue rising 10% to $4.07 billion, surpassing analyst expectations of $4.03 billion. The company generated a profit of $432.6 million, or $1.52 per...

Bullish Signals

  • Revenue grew 10% YoY to $4.07B, beating forecasts.
  • EPS rose to $1.52 from $1.44 last year.
  • Adjusted EPS of $1.70 matched Wall Street estimates.
  • Life-sciences sales jumped 11% led by bioprocessing.
  • Digital and high-tech units grew over 20%.

Bearish Signals

  • Full-year revenue relies on global energy surcharge until mid-year.
  • Commodity costs rise high-single-digits in Q2, hurting margins.
  • Q2 adjusted EPS guidance of $2.02-$2.12 beats analyst estimates.
  • Margins suffer during transition before surcharge offsets fuel prices.
23
Somewhat Bullish +35

Ecolab (ECL) Q3 Earnings Showcase Margin Strength Despite EPS Drag

Ecolab (ECL) reported Q3 2026 earnings that confirmed its status as a premium operator in global water, hygiene, and specialty chemicals. Despite trading at a high P/E of 39.2x, the stock edged up 0.8% to roughly US$291 after releasing results that showed significant operational strength....

Bullish Signals

  • Organic operating income margin reached 19.6%.
  • Global High-Tech segment surged 63% year-over-year.
  • Digital segment grew 34% year-over-year.
  • Integrating CoolIT, Ovivo, and Purolite for digital leadership.

Bearish Signals

  • Net income and EPS declined 5.8% and 4.7% YoY.
  • High capex and CoolIT acquisition limit near-term free cash flow.
  • CoolIT integration reduces adjusted EPS by $0.20/quarter in H2 2026.
24
Bullish +65

UBS raises target to USD 344 for Ecolab stock before results

UBS Group raised its price target for Ecolab Inc. to USD 344 on October 5, 2026, ahead of the company's scheduled third-quarter earnings release. This bullish adjustment comes as part of a generally positive analyst consensus, with MarketBeat reporting an average target of USD 324.50...

Bullish Signals

  • UBS raised price target to $344 on Oct 5, 2026.
  • Q2 revenue grew 9.70% YoY to $4.42 billion.
  • EPS of $2.09 beat consensus estimate of $2.08.
25
Bullish +65

Ecolab stock: UBS raises target for Ecolab stock to USD 344.00

Ecolab Inc. reported strong second-quarter 2026 financial results, with revenue reaching USD 4.42 billion, representing a 9.70 percent year-over-year increase. The company delivered diluted earnings per share of USD 1.90, which beat the consensus estimate of USD 2.08 according to MarketBeat data, while total revenue...

Bullish Signals

  • Revenue grew 9.7% YoY to USD 4.42B.
  • Revenue beat estimates at USD 4.42B.
  • UBS raised target to USD 344 and maintained Buy.